Testing treatments to improve symptoms of Myositis
Are You Eligible?Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.
Research Objectives
Status
Current
Recruitment
Open
Study location
Wesley Research Institute
Study type
Industry Sponsored
Patient group
Idiopathic Inflammatory Myopathy/Myositis Status: Current
Industry sponsor
Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)
About this clinical trial
The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.
The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.
Register your interest
If you would like more information about this clinical trial, please complete the contact form below.